Trilock 4 mg (Tablet)
Unit Price: ৳ 6.04 (3 x 14: ৳ 253.68)
Strip Price: ৳ 84.56
Medicine Details
Category | Details |
---|---|
Generic | Montelukast sodium |
Company | Opsonin pharma ltd |
Also available as |
Indications
- Prophylaxis and chronic treatment of asthma
- Acute prevention of Exercise-Induced Bronchoconstriction (EIB)
- Relief of symptoms of Allergic Rhinitis (AR): Seasonal & Perennial Allergic Rhinitis
Pharmacology
- Selective leukotriene receptor antagonist
- Orally active
- Inhibits cysteinyl leukotriene receptor (CysLT1)
- Correlated with the pathophysiology of asthma & allergic rhinitis
- Contributes to the signs and symptoms of asthma
- Released from various cells including mast cells and eosinophils
Dosage & Administration
- Adult dosage: Montelukast 10 mg tablet once daily
- Adolescent dosage: Montelukast 10 mg tablet once daily
- Pediatric dosage (6 to 14 years): Montelukast 5 mg tablet once daily
- Pediatric dosage (2 to 5 years): Montelukast 4 mg tablet once daily
- Pediatric dosage (6 months to 5 years): Montelukast 4 mg oral granules once daily
- Use in pediatric patients with asthma 6 months to 14 years of age
- Hepatic insufficiency: No dosage adjustment required
- Renal insufficiency: No dosage adjustment recommended
- Elderly use: No dosage adjustment required
Interaction
- No apparent increase in adverse reactions when administered with other therapies for asthma
- No clinically important effects on the pharmacokinetics of certain drugs
- Used concomitantly with a wide range of commonly prescribed drugs without evidence of clinical adverse interactions
- Phenobarbital decreased the AUC of Trilock approximately 40%
- No dosage adjustment recommended
Contraindications
- Hypersensitivity to any component of the product
Side Effects
- Common: Diarrhoea, fever, gastrointestinal discomfort, headache, nausea, vomiting, skin reactions, upper respiratory tract infection
- Uncommon: Akathisia, anxiety, arthralgia, asthenia, abnormal behavior, depression, dizziness, drowsiness, dry mouth, haemorrhage, irritability, malaise, muscle complaints, oedema, seizure, abnormal sensation, sleep disorders
- Rare: Angioedema, concentration impaired, disorientation, eosinophilic granulomatosis with polyangiitis, erythema nodosum, hallucination, hepatic disorders, memory loss, palpitations, pulmonary eosinophilia, suicidal tendencies, tremor
Pregnancy & Lactation
- Crosses the placenta following oral dosing in rats and rabbits
- Use during pregnancy only if clearly needed
- Caution should be exercised when given to a nursing mother
Precautions & Warnings
- Not indicated for use in the reversal of bronchospasm in acute asthma attacks
- Appropriate rescue medication should be available
- Can be continued during acute exacerbations of asthma
- Should not be abruptly substituted for inhaled or oral corticosteroids
- Not to be used as monotherapy for the treatment and management of exercise induced bronchospasm
- Patients with known aspirin sensitivity should continue avoidance of aspirin or non-steroidal anti-inflammatory agents
Overdose Effects
- No adverse experiences in the majority of overdosage reports
- The most frequently occurring adverse experiences were consistent with the safety profile of Trilock
Therapeutic Class
- Leukotriene receptor antagonists
Storage Conditions
- Store in cool & dry place below 30°C
- Protect from light & moisture
- Keep out of reach of children
Chemical Structure
- Molecular Formula: C35H36ClNO3S
Common Questions about Trilock 4 mg Tablet
- Selective and orally active leukotriene receptor antagonist
- Used to treat asthma or allergic rhinitis
- Effect can be observed after 1-3 hours of administration
- Lasts for an average duration of 24 hours
- May be taken with or without food as prescribed by your doctor
- Avoid changing dose without doctor's advice
- Not a fast-acting rescue medicine for asthma attacks
- Use during pregnancy should be avoided unless clearly needed
Related Brands
- Aeron FT 4 mg (Dispersible Tablet) - healthcare-pharmaceuticals-ltd
- Aeron FT 5 mg (Dispersible Tablet) - healthcare-pharmaceuticals-ltd
- Aeron 10 mg (Tablet) - healthcare-pharmaceuticals-ltd
- Montinex 4 mg (Chewable Tablet) - beacon-pharmaceuticals-plc
- Montinex 5 mg (Chewable Tablet) - beacon-pharmaceuticals-plc